BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1A through FIG. 1E are drawings showing a typical procedure for the immunoassay method of the related art;
FIG. 2A and FIG. 2B are drawings showing the state of the magnetic markers when the magnetic field is completely blocked, and the magnetic marker state when there is a residual magnetic field;
FIG. 3A, FIG, 3B and FIG. 3C are drawings showing the relation between the magnetization direction of the sample when using a magnetometer, to the detected magnetic signal waveform;
FIG. 4A, FIG, 4B and FIG. 4C are drawings showing the relation between the magnetization direction of the sample when using a first-order planar gradiometer, to the detected magnetic signal waveform;
FIG. 5 is a drawing showing a typical structure of the immunoassay system including a compensation coil for the first embodiment of this invention;
FIG. 6 is a drawing showing a sample container used in the first embodiment;
FIG. 7 is a drawing showing the high-temperature superconducting SQUID used in the embodiment of this invention;
FIG. 8 is a flow chart showing the test protocol used in the embodiment;
FIG. 9A is a magnetic signal waveform obtained from a sample containing 100 pg of IgE measured with no electrical current flowing in the compensation coil;
FIG. 9B is a magnetic signal waveform obtained from a reference sample not containing IgE and measured with no electrical current flowing in the compensation coil;
FIG. 10 is magnetic signal waveforms from the reference sample showing the compensation coil current dependence;
FIG. 11A is a magnetic signal waveform obtained from a sample containing 100 pg of IgE measured with an electrical current of 200 μA flowing in the compensation coil;
FIG. 11B is a magnetic signal waveform obtained from a reference sample not containing IgE measured with an electrical current of 200 μA flowing in the compensation coil;
FIG. 12A is a waveform obtained from a sample where bilaterally symmetrical components were eliminated from the magnetic signal waveform measured with an electrical current of 200 μA flowing in the compensation coil;
FIG. 12B is a waveform of the reference sample not containing IGE and measured with an electrical current of 200 μA flowing in the compensation coil;
FIG. 13 is a drawing showing the structure of the immunoassay system of the second embodiment;
FIG. 14A is a magnetic signal waveform obtained in the second embodiment from a sample containing 100 pg of IgE;
FIG. 14B is a magnetic signal waveform obtained in the second embodiment from a reference sample not containing IgE.
FIG. 15 is a drawing showing the structure of the immunoassay system of the third embodiment;
FIG. 16A is a magnetic signal waveform obtained in the third embodiment from a sample (solid line) containing 100 pg of IgE; and
FIG. 16B is a magnetic signal waveform obtained in the third embodiment from a reference sample (dotted line) not containing IgE.